BAX Financial Facts
Research and development expenses: 159MGross margin: 1.07B
See Full Income Statement
Total liabilities and equity: 15.8B
Total Baxter shareholders' equity: 8.68B
See Full Balance Sheet
Baxter (BAX) Earnings
|
Expand Research on BAX
| Next EPS Date | 10/30/26 *Est. | EPS Growth Rate | -5.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +15.1% | Revenue Growth Rate | +5.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/30/26 | Q226 | $0.56 | $0.37 | +$0.19 | $2.96B | $2.8B | = |  | | Details | |
| 4/30/26 | Q126 | $0.36 | $0.32 | +$0.04 | $2.7B | $2.62B | = | | | Details | |
| 2/12/26 | Q425 | $0.44 | $0.54 | -$0.10 | $2.97B | $2.84B | = | | | Details | |
| 10/30/25 | Q325 | $0.69 | $0.60 | +$0.09 | $2.84B | $2.88B | = | | | Details | |
| 7/31/25 | Q225 | $0.59 | $0.61 | -$0.02 | $2.81B | $2.82B | = | | | Details | |
| 5/1/25 | Q125 | $0.55 | $0.48 | +$0.07 | $2.63B | $2.59B | = | | | Details | |
| 2/20/25 | Q424 | $0.58 | $0.52 | +$0.06 | $2.75B | $2.67B | = | | | Details | |
| 11/8/24 | Q324 | $0.80 | $0.78 | +$0.02 | $3.85B | $3.85B | = | | | Details |
